Stock Scorecard



Stock Summary for Cassava Sciences Inc (SAVA) - $27.08 as of 10/4/2024 9:27:46 PM EST

Total Score

11 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SAVA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SAVA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SAVA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SAVA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for SAVA

SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims 9/30/2024 2:05:00 PM
Company News for Sep 30, 2024 9/30/2024 1:18:00 PM
Why Cassava Sciences Stock Dived by Almost 11% Today 9/27/2024 10:05:00 PM
Cassava Sciences Unusual Options Activity - Cassava Sciences ( NASDAQ:SAVA ) 9/27/2024 3:17:00 PM
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cassava Sciences ( NASDAQ:SAVA ) 9/27/2024 12:47:00 PM
SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty - Cassava Sciences ( NASDAQ:SAVA ) 9/27/2024 12:28:00 PM
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Establishment Labs Hldgs ( NASDAQ:ESTA ) 9/27/2024 10:46:00 AM
Friday's big stock stories: What's likely to move the market in the next trading session 9/26/2024 11:43:00 PM
Cassava Sciences Resolves SEC Investigation 9/26/2024 10:15:00 PM
Cassava Sciences Resolves SEC Investigation - Cassava Sciences ( NASDAQ:SAVA ) 9/26/2024 10:15:00 PM

Financial Details for SAVA

Company Overview

Ticker SAVA
Company Name Cassava Sciences Inc
Country USA
Description Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2024
Next Earnings Date 11/5/2024

Stock Price History

Last Day Price 27.08
Last Day Price Updated 10/4/2024 9:27:46 PM EST
Last Day Volume 790,109
Average Daily Volume 1,652,689
52-Week High 42.20
52-Week Low 8.79
Last Price to 52 Week Low 208.08%

Valuation Measures

Trailing PE N/A
Industry PE 35.61
Sector PE 81.40
5-Year Average PE -13.01
Free Cash Flow Ratio 6.27
Industry Free Cash Flow Ratio 12.88
Sector Free Cash Flow Ratio 32.90
Current Ratio Most Recent Quarter 4.07
Total Cash Per Share 4.32
Book Value Per Share Most Recent Quarter 3.94
Price to Book Ratio 6.85
Industry Price to Book Ratio 5.95
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 7.08
Sector Price to Sales Ratio Twelve Trailing Months 6.36

Share Statistics

Total Shares Outstanding 47,976,200
Market Capitalization 1,299,195,496
Institutional Ownership N/A

Dividends

Ex-Dividend Date 12/13/2012
Last Dividend Amount 14.00
Current Dividend Amount 5.25
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage -62.50%
3-Year Dividend Growth Rate Percentage -62.50%
5-Year Dividend Growth Rate Percentage -62.50%
All-Time Dividend Growth Rate Percentage -62.50%
Dividend Payout Ratio 0.00%

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -27.50%
Reported EPS 12 Trailing Months -2.83
Reported EPS Past Year 0.71
Reported EPS Prior Year -2.32
Net Income Twelve Trailing Months -15,372,000
Net Income Past Year -97,217,000
Net Income Prior Year -76,246,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 207,291,000
Total Cash Past Year 121,136,000
Total Cash Prior Year 201,015,000
Net Cash Position Most Recent Quarter 207,291,000
Net Cash Position Past Year 121,136,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 137,468,000
Total Stockholder Equity Prior Year 227,539,000
Total Stockholder Equity Most Recent Quarter 188,974,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -86,306,000
Free Cash Flow Per Share Twelve Trailing Months -1.80
Free Cash Flow Past Year -82,439,000
Free Cash Flow Prior Year -80,226,000

Options

Put/Call Ratio 0.32
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.33
MACD Signal 1.43
20-Day Bollinger Lower Band 8.10
20-Day Bollinger Middle Band 21.50
20-Day Bollinger Upper Band 34.91
Beta -0.63
RSI 58.46
50-Day SMA 21.52
150-Day SMA 27.81
200-Day SMA 33.50

System

Modified 10/4/2024 12:46:21 PM EST